.png)
Key BenefitsDrug Pricing Germany Plus V is an optional supplement to the Drug Pricing Germany tool. It provides the information needed to bill articles in accordance with national and regional delivery contracts, with a focus on assistive products.
The module supports providers in the often complicated and time-consuming price determination of assistive products. Prices and billing details can be retrieved via the PZN and the assistive-product position numbers.
The data originates from ABDATA Pharma-Daten-Service in Eschborn and is updated monthly. Drug Pricing Germany Plus V requires the Drug Pricing or Premium subscription.
Determine prices for assistive products, dressings, and medical devices that qualify for prescription under Annex V.
Bill articles in line with the delivery and supply contracts that apply nationally and at the regional fund level.
Account for the delivery exclusions and approval limits that individual health insurance funds apply.
Reach the pricing and billing details for an article through both the Pharmazentralnummer and the assistive-product position number, working from a dataset that is refreshed every month.
Assistive products sit at the intersection of pharmaceutical distribution and statutory health insurance rules. Their reimbursement is governed less by a single national price and more by a web of delivery and supply contracts that differ between funds and regions. For providers, this makes correct billing a demanding, detail-heavy task.
Unlike standard pharmaceuticals, assistive products are billed against contracts negotiated under the German Social Code (SGB V). Rules such as delivery exclusions from tenders (§ 127 SGB V) and billing requirements under § 302 SGB V vary by fund, so the same article can carry different conditions depending on the patient's insurer.
Drug Pricing Germany Plus V consolidates the relevant contract and billing information so that prices can be determined via the PZN and the assistive-product position numbers. With monthly updates, providers can keep pace with changing contracts and fund-specific arrangements.
